flurbiprofen has been researched along with Respiratory Tract Infections in 5 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of a combined topical drug with flurbiprofen and cetylpyridinium chloride in patients with sore throat caused by upper respiratory tract infections." | 9.51 | [Results of a clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. ( Galustyan, AN; Gonik, MI; Sedavnykh, IS, 2022) |
| "Randomized, double-blind study in adults with sore throat due to upper respiratory tract infection who took flurbiprofen (n = 249) or placebo spray (n = 256)." | 9.27 | Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection. ( Bloch, M; de Looze, F; DeVito, R; Montgomery, B; Russo, M; Shephard, A, 2018) |
| " Adults with sore throat due to upper respiratory tract infection (onset ≤ four days) took one dose of flurbiprofen (n = 249) or placebo spray (n = 256); after six hours, they could re-dose every three-six hours as required, for three days (max." | 9.22 | Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: A randomised controlled trial. ( Aspley, S; Bloch, M; de Looze, F; Montgomery, B; Russo, M; Shephard, A; Smith, G, 2016) |
| "To evaluate the efficacy and safety of a combined topical drug with flurbiprofen and cetylpyridinium chloride in patients with sore throat caused by upper respiratory tract infections." | 5.51 | [Results of a clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. ( Galustyan, AN; Gonik, MI; Sedavnykh, IS, 2022) |
| "Randomized, double-blind study in adults with sore throat due to upper respiratory tract infection who took flurbiprofen (n = 249) or placebo spray (n = 256)." | 5.27 | Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection. ( Bloch, M; de Looze, F; DeVito, R; Montgomery, B; Russo, M; Shephard, A, 2018) |
| " Adults with sore throat due to upper respiratory tract infection (onset ≤ four days) took one dose of flurbiprofen (n = 249) or placebo spray (n = 256); after six hours, they could re-dose every three-six hours as required, for three days (max." | 5.22 | Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: A randomised controlled trial. ( Aspley, S; Bloch, M; de Looze, F; Montgomery, B; Russo, M; Shephard, A; Smith, G, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galustyan, AN | 1 |
| Sedavnykh, IS | 1 |
| Gonik, MI | 1 |
| de Looze, F | 2 |
| Russo, M | 2 |
| Bloch, M | 2 |
| Montgomery, B | 2 |
| Shephard, A | 2 |
| DeVito, R | 1 |
| Smith, G | 1 |
| Aspley, S | 1 |
| Sedinkin, AA | 1 |
| Balandin, AV | 1 |
| Dimova, AD | 1 |
| Tamura, M | 1 |
| Ito, T | 1 |
| Sudo, M | 1 |
| Tazawa, M | 1 |
| Sayama, T | 1 |
| Yoshida, M | 1 |
| Suzuki, A | 1 |
| Sato, M | 1 |
| Murakami, T | 1 |
| Miyamoto, S | 1 |
5 trials available for flurbiprofen and Respiratory Tract Infections
| Article | Year |
|---|---|
[Results of a clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pharyngitis; Pro | 2022 |
Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Flurbiprofen; Hu | 2018 |
Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: A randomised controlled trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Australia; Double-Blind Method; Fe | 2016 |
[Results of an open prospective controlled randomized comparative trial of efficacy and tolerance of sublingual tablets flurbiprofen (strepfen) and paracetamol in patients with throat pain in acute infectious-inflammatory diseases of the upper respiratory
Topics: Acetaminophen; Analgesics, Non-Narcotic; Drug Hypersensitivity; Flurbiprofen; Humans; Pain; Prospect | 2004 |
[A double-blind clinical evaluation of flurbiprofen on acute upper respiratory tract inflammation--comparative study with ibuprofen].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Humans | 1984 |